Prepregnancy habitual intake of vitamin D from diet and supplements in relation to risk of gestational diabetes mellitus: A prospective cohort study
Journal of Diabetes, EarlyView. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 18, 2017 Category: Endocrinology Source Type: research
---
Journal of Diabetes, Ahead of Print. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 18, 2017 Category: Endocrinology Source Type: research
Prepregnancy habitual intake of vitamin D from diet and supplements in relation to risk of gestational diabetes mellitus: A prospective cohort study
ConclusionsPrepregnancy supplemental vitamin D intake was significantly and inversely associated with risk of GDM. This study indicates potential benefits of increasing vitamin D intake from supplements in the prevention of GDM in women of reproductive age. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 18, 2017 Category: Endocrinology Authors: Wei Bao, Yiqing Song, Kimberly A. Bertrand, Deirdre K. Tobias, Sjurdur F. Olsen, Jorge E. Chavarro, James L. Mills, Frank B. Hu, Cuilin Zhang Tags: Original Article Source Type: research
Re ‐examining the sensitivity of HbA1c to screen for diabetes mellitus
Journal of Diabetes, EarlyView. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 11, 2017 Category: Endocrinology Source Type: research
---
Journal of Diabetes, Ahead of Print. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 11, 2017 Category: Endocrinology Source Type: research
Re ‐examining the sensitivity of HbA1c to screen for diabetes mellitus
ConclusionsThe sensitivity of HbA1c as a screening test for DM in this study was significantly higher than that reported previously. This work provides additional evidence supporting the inclusion of HbA1c as one of the screening tests for DM. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 11, 2017 Category: Endocrinology Authors: Chun W. Yap, Yee G. Ang, Timothy P.L. Quek, Bee H. Heng, Daniel E.K. Chew Tags: Original Article Source Type: research
European Association for the Study of Diabetes 2017
Ann M. Carracher, Payal H. Marathe, and Kelly L. Close are of Close Concerns (http://www.closeconcerns.com), a healthcare information company focused exclusively on diabetes and obesity care. Close Concerns publishes Closer Look, a periodical that brings together news and insights in these areas. Each month, the Journal of Diabetes includes this News feature, in which Carracher, Marathe, and Close review the latest developments relevant to researchers and clinicians. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 11, 2017 Category: Endocrinology Authors: Ann M. Carracher, Payal H. Marathe, Kelly L. Close Tags: News Source Type: research
Challenges of the economic and social effects of diabetes in low ‐ and middle‐income countries
Journal of Diabetes,Volume 10, Issue 4, Page 344-345, April 2018. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 5, 2017 Category: Endocrinology Source Type: research
High dietary intakes of branched ‐chain amino acids is associated with increased risk of insulin resistance in adults
ConclusionOur findings support the hypothesis that higher intakes of BCAAs may have adverse effects on development of IR. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Golaleh Asghari, Hossein Farhadnejad, Farshad Teymoori, Parvin Mirmiran, Maryam Tohidi, Fereidoun Azizi Tags: Original Article Source Type: research
Type 1 Diabetes Mellitus Associated with Activated Phosphoinositide ‐3‐kinase Delta Syndrome, Type 2
Abstract
Primary immunodeficiency (PID) is a disorder in which the immune system does not function normally1. In addition to the increased risk of infection, autoimmune disorders are often observed in PID.1 (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Ryuichi Nakagawa, Kei Takasawa, Tzu ‐Wen Yeh, Kohsuke Imai, Kenichi Kashimada, Tomohiro Morio Tags: Letter to the Editor Source Type: research
Diabetes News
Abstract
The American Heart Association's 2017 Scientific Sessions took place in November 2017 in Anaheim, CA, USA. Dr Kenneth Mahaffey (Stanford University, CA, USA) discussed a subgroup analysis1 of the Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes (CANVAS) trial,2 suggesting consistent heart failure and renal benefits to the sodium/glucose cotransporter 2 (SGLT‐2) inhibitor Invokana (canagliflozin) across primary and secondary prevention cohorts. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Ann M. Carracher, Payal H. Marathe, Kelly L. Close Tags: News Source Type: research
Fulminant type 1 diabetes caused by peginterferon α‐2a therapy in hepatitis C
Abstract
Interferon therapy can increase the risk of type 1 diabetes (T1D) in patients with hepatitis C. Fulminant type 1 diabetes (FT1D) is a novel subtype of T1D characterized by extremely rapid progression1. However, the relationship between interferon therapy and FT1D remains to be identified. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Ying Zheng, Zhen Wang, Zhiguo Xie, Ruchun Dai, Zhiguang Zhou Tags: Letter to the Editor Source Type: research
Indoor renovation and diabetes mellitus: evidence from a cohort study
Abstract
Diabetes mellitus, a major global challenge, caused death every 6 seconds in 2015. In the same year, 12% of global health expenditure was spent on diabetes.1 Preventing development of diabetes is a meaningful topic. (Source: Journal of Diabetes)
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Nan Zhang, Xiang Hu, Tian Shu Zeng, Jiao ‐Yue Zhang, Sheng‐Hua Tian, Jie Min, Han‐Tao Huang, Juan Zheng, Xiuling Deng, Lu‐Lu Chen Tags: Rapid Publication Source Type: research
Dapagliflozin as Add ‐on Therapy in Asian Patients with Type 2 Diabetes Inadequately Controlled on Insulin ± Oral Antihyperglycemic Drugs: A Randomized Controlled Trial
ConclusionsDapagliflozin as add‐on to insulin ± OADs significantly improved glycemic control and reduced body weight and blood pressure in Asian patients. Dapagliflozin was well tolerated, with a similar frequency of hypoglycemia in both groups. These results support the use of dapagliflozin as add‐on to insulin ± OADs in this population.This study was funded by AstraZeneca.
HighlightsDapagliflozin 10 mg as add‐on to insulin ± oral antihyperglycemic drugs significantly improved glycemic control and reduced body weight and blood pressure, without increased risk of hypoglycemia, compared with placebo in this 24‐we...
Source: Journal of Diabetes - December 1, 2017 Category: Endocrinology Authors: Wenying Yang, Jianhua Ma, Yiming Li, Yanbing Li, Zhiguang Zhou, Jae Hyeon Kim, June Zhao, Agata Ptaszynska Tags: Original Article Source Type: research
